CD33 and gastric cancer: To enhance our understanding of the contribution of the local immune response to the progression of gastric cancer, this study characterized CD8+ T lymphocytes, CD20+ B lymphocytes, and CD33+/p-STAT1+ cells in the intratumoral region.